Plain-English translation of NCT07728123 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Screen2Prevent is testing the best way to offer HIV screening to young people ages 14–24 who visit emergency rooms. The study uses a simple tablet survey to ask about sexual health and whether someone wants to be tested for HIV. Researchers will also send text messages with information about HIV prevention medication called PrEP (pre-exposure prophylaxis) to help connect interested patients with prevention services.
Many young people don't get screened for HIV early enough, even though early detection and prevention are life-changing. This trial is looking for the most effective way to offer screening in emergency rooms—places where teens and young adults already come for care—so that more people can learn their status and access prevention medication.
You likely qualify if…
You likely don't qualify if…
If you agree to participate, you would use a tablet in the emergency room to answer questions about your sexual health and decide whether you want to be tested for HIV. There is no pressure—you can skip the survey or stop at any time. If your answers suggest HIV testing or prevention medication might be right for you, the emergency room doctor will receive a recommendation to discuss this with you. You may also receive text messages with information about HIV prevention and how to connect with support services. The entire study lasts 24 months, but your participation happens during your emergency room visit.
AI-generated summary from trial data · Aug 23, 2026 · Not medical advice
United States